Press Releases & Media

Date Title and Summary Additional Formats
Toggle Summary Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says Lyle Probst During BioWatch Panel
Probst's comments were delivered yesterday afternoon during a two-day BioWatch Workshop on "Strategies for Effective Biological Detection Systems" held in Washington, D.C. at the National Academies of Sciences, Engineering, and Medicine. During his presentation, Probst also shared specific scientific data about pathogen detection results delivered by ExcitePCR's FireflyDX technologies
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary CEO to Speak on National Academies of Science, Engineering, and Medicine Panel Today
Three-person BioWatch panel on current and future advancements in pathogen detection systems will be held at 3:30 pm in Washington, D.C.
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary CEO Lyle Probst Invited to Join Prestigious BioWatch Panel During Two-Day Workshop Hosted by the National Academies of Science, Engineering, and Medicine
Sixty-minute panel about current and future advancements in pathogen detection systems to be held at 3:30 p.m. (ET) on Mon., Sept. 18 at the National Academy of Sciences in Washington, D.C.
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
Recent market developments inspire ExcitePCR management to expand its product strategy to a planned rollout of a FireflyDX family of realtime pathogen detection systems, with the FireflyDX-Portable launch scheduled for the summer of 2018 and the FireflyDX-Handheld targeted for availability in 2019
View HTML
Toggle Summary PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the 2017 Fall Hospital Supply Chain Conference September 18-20th
DELRAY BEACH, Fla. , Aug. 29, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTCQB:PSID), a Life Sciences Company focused on detection and diagnostics, announced today that its Thermomedics subsidiary will exhibit the Caregiver® non-contact thermometer at the 2017 Fall Hospital Supply Chain
View HTML
Toggle Summary PositiveID's Subsidiary, ExcitePCR, Hires Thirty-Year Marketing Veteran, David L. Politis, as its Chief Marketing & Sales Officer
DELRAY BEACH, Fla. , Aug. 24, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTCQB:PSID), a life sciences company focused on detection and diagnostics, today announced that its subsidiary, ExcitePCR Corporation , has hired David L. Politis as its Chief Marketing & Sales Officer.
View HTML
Toggle Summary PositiveID's E-N-G Mobile Labs Revenues for First Eight Months of 2017 Exceed Full Year 2016 Mobile Labs Revenues by 19%
Mobile labs revenues represent more than 50% of total revenue for its specialty vehicle business, up from 24% for the full year 2016
View HTML
Toggle Summary PositiveID Reports Second Quarter 2017 Results
Company Projects Full Year Revenue Growth for 2017
View HTML
Toggle Summary PositiveID Issues Statement About Promotional Activity Concerning Its Common Stock
DELRAY BEACH, Fla. , Aug. 14, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a Life Sciences company focused on detection and diagnostics, announced today that the OTC Markets Group made the Company aware of promotional activity regarding its shares.
View HTML
Toggle Summary PositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype System
Company publishes white paper and data on Ebola detection
View HTML